Yvette Chen vividly recalls sitting amidst a group of freshly minted high school students, listening as they spoke of dreams that had once been out of reach. “They talked about the colleges they wanted to attend, the majors they wanted to study, and the careers they aspired to build,” says Temasek’s Vice President for Investments, Shanghai.
“In China, especially in the underdeveloped and rural areas, education is everything,” she explains. “It’s a chance to change your path in life.”
It was this that inspired Yvette and her Temasek colleagues to sponsor a ‘Pearl Class’ under China NGO Xin Hua Compassion Education Foundation’s Hope for Pearl initiative. Through this programme, students who perform well academically but lack the means to complete their education are offered a place in a “Pearl Class”, often in one of the top schools in the area they live in.
The sponsorship was a way for Temasek’s staff to make a difference in the community, she says.
“Many people want to give back, but lack the right platform. Temasek not only supports these opportunities, but fosters a culture of giving back.”
Yvette’s passion resonates with many of her colleagues. “Education transformed our lives – without it, many of us wouldn’t be where we are today,” she says. “Now we have the ability to help others.”
Building for the future
A finance graduate, Yvette joined Temasek’s life sciences team in Shanghai in 2014. “At that time, China was beginning its shift from generic to innovator drugs,” she recalls. “As one of the earliest investors in this emerging field, we witnessed the evolution of its capabilities in drug innovation.”
“The office was very small then,” she says. “When I first joined, there were about ten people, so when we went for a team lunch, we only needed one table.” As Temasek’s interest in China grew, one table became two, then three, and then four. “Today, we have a large portfolio of companies across various sectors, and the Shanghai office has almost 50 people, so we need five tables,” she laughs. “That's how quickly we’ve expanded. In just ten years, we’ve been able to create a really meaningful presence in China.”
Yvette’s own role has grown from conducting due diligence as an investment associate, to identifying trends, pinning down strategies, and contributing to the broader growth of the company in her current role. “I have spent the majority of my career in biopharma, and work closely with our global life sciences team in Singapore. Most recently, our focus has been on creating a life sciences innovation park in Suzhou to help foster an ecosystem, and support the growth and internationalisation of innovative companies,” she says.